Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Dec. 31, 2021 $ 3,276 $ 123,827,646 $ (76,696,719) $ 47,134,203
Balance, beginning, shares at Dec. 31, 2021 32,768,184      
Stock-based compensation expense   952,828   952,828
Issuance of restricted stock for services $ (51) 51    
Issuance of restricted stock for services (in shares) (509,527)      
Net loss     (9,924,029) (9,924,029)
Balance, ending at Mar. 31, 2022 $ 3,225 124,780,525 (86,620,748) 38,163,002
Balance, ending, shares at Mar. 31, 2022 32,258,657      
Balance, beginning at Dec. 31, 2022 $ 3,315 125,333,873 (107,113,392) 18,223,796
Balance, beginning, shares at Dec. 31, 2022 33,155,356      
Stock-based compensation expense   316,689   316,689
Exercise of stock options $ 66 655   $ 721
Exercise of stock options (in shares) 655,000     655,000
Net loss     (4,093,113) $ (4,093,113)
Balance, ending at Mar. 31, 2023 $ 3,381 $ 125,651,217 $ (111,206,505) $ 14,448,093
Balance, ending, shares at Mar. 31, 2023 33,810,356